Outset Medical Statistics
Total Valuation
Outset Medical has a market cap or net worth of $234.34 million. The enterprise value is $149.03 million.
Important Dates
The last earnings date was Wednesday, August 6, 2025, after market close.
Earnings Date | Aug 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Outset Medical has 17.77 million shares outstanding. The number of shares has increased by 135.33% in one year.
Current Share Class | 17.77M |
Shares Outstanding | 17.77M |
Shares Change (YoY) | +135.33% |
Shares Change (QoQ) | +152.10% |
Owned by Insiders (%) | 2.04% |
Owned by Institutions (%) | 58.93% |
Float | 10.93M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.88 |
Forward PS | 1.80 |
PB Ratio | 1.55 |
P/TBV Ratio | 1.55 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1.25 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.47, with a Debt / Equity ratio of 0.64.
Current Ratio | 7.47 |
Quick Ratio | 5.93 |
Debt / Equity | 0.64 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -4.03 |
Financial Efficiency
Return on equity (ROE) is -87.65% and return on invested capital (ROIC) is -18.17%.
Return on Equity (ROE) | -87.65% |
Return on Assets (ROA) | -15.79% |
Return on Invested Capital (ROIC) | -18.17% |
Return on Capital Employed (ROCE) | -30.25% |
Revenue Per Employee | $337,017 |
Profits Per Employee | -$276,559 |
Employee Count | 354 |
Asset Turnover | 0.40 |
Inventory Turnover | 1.33 |
Taxes
In the past 12 months, Outset Medical has paid $397,000 in taxes.
Income Tax | 397,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.08% in the last 52 weeks. The beta is 2.14, so Outset Medical's price volatility has been higher than the market average.
Beta (5Y) | 2.14 |
52-Week Price Change | -0.08% |
50-Day Moving Average | 18.24 |
200-Day Moving Average | 14.33 |
Relative Strength Index (RSI) | 34.64 |
Average Volume (20 Days) | 365,610 |
Short Selling Information
The latest short interest is 2.16 million, so 12.13% of the outstanding shares have been sold short.
Short Interest | 2.16M |
Short Previous Month | 2.19M |
Short % of Shares Out | 12.13% |
Short % of Float | 19.72% |
Short Ratio (days to cover) | 7.49 |
Income Statement
In the last 12 months, Outset Medical had revenue of $119.30 million and -$97.90 million in losses. Loss per share was -$12.30.
Revenue | 119.30M |
Gross Profit | 43.87M |
Operating Income | -76.19M |
Pretax Income | -158.67M |
Net Income | -97.90M |
EBITDA | -70.95M |
EBIT | -76.19M |
Loss Per Share | -$12.30 |
Full Income Statement Balance Sheet
The company has $184.09 million in cash and $98.43 million in debt, giving a net cash position of $85.66 million or $4.82 per share.
Cash & Cash Equivalents | 184.09M |
Total Debt | 98.43M |
Net Cash | 85.66M |
Net Cash Per Share | $4.82 |
Equity (Book Value) | 154.78M |
Book Value Per Share | 8.50 |
Working Capital | 238.67M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$67.54 million and capital expenditures -$853,000, giving a free cash flow of -$68.40 million.
Operating Cash Flow | -67.54M |
Capital Expenditures | -853,000 |
Free Cash Flow | -68.40M |
FCF Per Share | -$3.85 |
Full Cash Flow Statement Margins
Gross margin is 36.77%, with operating and profit margins of -63.87% and -82.06%.
Gross Margin | 36.77% |
Operating Margin | -63.87% |
Pretax Margin | -81.73% |
Profit Margin | -82.06% |
EBITDA Margin | -59.47% |
EBIT Margin | -63.87% |
FCF Margin | n/a |
Dividends & Yields
Outset Medical does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -135.33% |
Shareholder Yield | -135.33% |
Earnings Yield | -41.72% |
FCF Yield | -29.14% |
Analyst Forecast
The average price target for Outset Medical is $33.50, which is 153.98% higher than the current price. The consensus rating is "Buy".
Price Target | $33.50 |
Price Target Difference | 153.98% |
Analyst Consensus | Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | 13.72% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on March 20, 2025. It was a reverse split with a ratio of 1:15.
Last Split Date | Mar 20, 2025 |
Split Type | Reverse |
Split Ratio | 1:15 |
Scores
Outset Medical has an Altman Z-Score of -4.4 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -4.4 |
Piotroski F-Score | 5 |